Vanda Pharmaceuticals (VNDA) Return on Capital Employed Growth (1y) (2012 - 2026)
Vanda Pharmaceuticals (VNDA) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 472.11 Bn | 467.32 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 121.89 Bn | 114.65 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - | - |
| 8 | Argenx Se | 55.82 Bn | 50.63 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.49 Bn | 37.49 Bn | - | -3,457.00 |
| 10 | Vanda Pharmaceuticals | 314.54 Mn | 112.23 Mn | 48.56 Mn | -3,583.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,583.00 |
| Dec 31, 2025 | -3,042.00 |
| Sep 30, 2025 | -1,776.00 |
| Jun 30, 2025 | -1,407.00 |
| Mar 31, 2025 | -889.00 |
| Dec 31, 2024 | -488.00 |
| Sep 30, 2024 | -666.00 |
| Jun 30, 2024 | -756.00 |
| Mar 31, 2024 | -745.00 |
| Dec 31, 2023 | -368.00 |
| Sep 30, 2023 | -164.00 |
| Jun 30, 2023 | -120.00 |
| Mar 31, 2023 | -182.00 |
| Dec 31, 2022 | -705.00 |
| Sep 30, 2022 | -717.00 |
| Jun 30, 2022 | -552.00 |
| Mar 31, 2022 | -316.00 |
| Dec 31, 2021 | 229.00 |
| Sep 30, 2021 | 409.00 |
| Jun 30, 2021 | 295.00 |